Chemed Net Income 2012-2026 | CHE
Chemed annual/quarterly net income history and growth rate from 2012 to 2026. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Chemed net income for the quarter ending March 31, 2026 was $0.066B, a 7.6% decline year-over-year.
- Chemed net income for the twelve months ending March 31, 2026 was $0.260B, a 15.86% decline year-over-year.
- Chemed annual net income for 2025 was $0.265B, a 12.17% decline from 2024.
- Chemed annual net income for 2024 was $0.302B, a 10.82% increase from 2023.
- Chemed annual net income for 2023 was $0.273B, a 9.17% increase from 2022.
|
Chemed Annual Net Income (Millions of US $) |
|
|---|---|
| 2025 | $265 |
| 2024 | $302 |
| 2023 | $273 |
| 2022 | $250 |
| 2021 | $269 |
| 2020 | $319 |
| 2019 | $220 |
| 2018 | $206 |
| 2017 | $98 |
| 2016 | $109 |
| 2015 | $110 |
| 2014 | $99 |
| 2013 | $77 |
| 2012 | $89 |
| 2011 | $86 |
|
Chemed Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2026-03-31 | $66 |
| 2025-12-31 | $77 |
| 2025-09-30 | $64 |
| 2025-06-30 | $52 |
| 2025-03-31 | $72 |
| 2024-12-31 | $90 |
| 2024-09-30 | $76 |
| 2024-06-30 | $71 |
| 2024-03-31 | $65 |
| 2023-12-31 | $90 |
| 2023-09-30 | $75 |
| 2023-06-30 | $53 |
| 2023-03-31 | $54 |
| 2022-12-31 | $62 |
| 2022-09-30 | $57 |
| 2022-06-30 | $66 |
| 2022-03-31 | $64 |
| 2021-12-31 | $75 |
| 2021-09-30 | $72 |
| 2021-06-30 | $57 |
| 2021-03-31 | $65 |
| 2020-12-31 | $114 |
| 2020-09-30 | $68 |
| 2020-06-30 | $82 |
| 2020-03-31 | $56 |
| 2019-12-31 | $66 |
| 2019-09-30 | $59 |
| 2019-06-30 | $51 |
| 2019-03-31 | $45 |
| 2018-12-31 | $54 |
| 2018-09-30 | $51 |
| 2018-06-30 | $55 |
| 2018-03-31 | $45 |
| 2017-12-31 | $55 |
| 2017-09-30 | $35 |
| 2017-06-30 | $-22 |
| 2017-03-31 | $30 |
| 2016-12-31 | $32 |
| 2016-09-30 | $27 |
| 2016-06-30 | $25 |
| 2016-03-31 | $25 |
| 2015-12-31 | $30 |
| 2015-09-30 | $29 |
| 2015-06-30 | $27 |
| 2015-03-31 | $25 |
| 2014-12-31 | $30 |
| 2014-09-30 | $25 |
| 2014-06-30 | $24 |
| 2014-03-31 | $21 |
| 2013-12-31 | $23 |
| 2013-09-30 | $17 |
| 2013-06-30 | $15 |
| 2013-03-31 | $22 |
| 2012-12-31 | $27 |
| 2012-09-30 | $21 |
| 2012-06-30 | $21 |
| 2012-03-31 | $20 |
| 2011-12-31 | $26 |
| 2011-09-30 | $22 |
| 2011-06-30 | $20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |